Laura Kupsch

Vice President Quality Assurance at Passage Bio, Inc.

Laura Kupsch

Laura Kupsch

Vice President Quality Assurance at Passage Bio, Inc.

Overview
RelSci Relationships

159

Relationships
RelSci Relationships are individuals Laura Kupsch likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Vice President, Corporate Affairs & General Counsel at Gilead Sciences, Inc.

Relationship likelihood: Strong

Executive Chairman at 4d Molecular Therapeutics, Inc.

Relationship likelihood: Strong

Vice Chairman at The National Health Museum

Relationship likelihood: Strong

Director at Gilead Pharmasset LLC

Relationship likelihood: Strong

Clinical Operations Manager at Gilead Pharmasset LLC

Relationship likelihood: Strong

Director of Chemical Research at Gilead Pharmasset LLC

Relationship likelihood: Strong

Co-Founder at Outpost Medicine LLC

Relationship likelihood: Strong

Vice President-Corporate Communications at Passage Bio, Inc.

Relationship likelihood: Strong

Vice President, Human Resources at Passage Bio, Inc.

Relationship likelihood: Strong

Vice President Clinical Development at Passage Bio, Inc.

Relationship likelihood: Strong

Paths to Laura Kupsch
Potential Connections via
Relationship Science
You
Laura Kupsch
Vice President Quality Assurance at Passage Bio, Inc.
Career History
Senior Director Quality Assurance
Tenure Unconfirmed

Gilead Pharmasset LLC, a subsidiary of Gilead Sciences, Inc., is a company headquartered in Princeton, NJ. The firm discovers, develops and commercializes therapeutic products and treatments for viral diseases.

Vice President Quality Assurance
Current

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Other Affiliations

Laura Kupsch is affiliated with Gilead Pharmasset LLC, Passage Bio, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Laura Kupsch. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Laura Kupsch's profile does not indicate a business or promotional relationship of any kind between RelSci and Laura Kupsch.